Market Challenges: Navigating High Treatment Costs and Generic Drug Competition
Despite the high growth potential and continuous innovation, the Epilepsy Diagnosis and Treatment Market faces significant headwinds, primarily related to high treatment costs, patient affordability, and the constant evolution of the generic drug landscape. These constraints temper the market's expansion, particularly in low- and middle-income regions where the disease burden is highest. The...
0 Comentários 0 Compartilhamentos 729 Visualizações 0 Anterior
Patrocinado